Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1730)
GLAUKOS Corp (GKOS)
Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Shares
345
Price
$164.60
Total Value
$56.79K
Shares Held After
73,442
% of Holdings
0.5%
GLAUKOS Corp (GKOS)
Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Shares
103
Price
$163.20
Total Value
$16.81K
Shares Held After
73,787
% of Holdings
0.1%
TELA Bio, Inc. (TELA)
Capper Joseph H — Director
Shares
50,000
Price
$1.17
Total Value
$58.27K
Shares Held After
154,827
% of Holdings
32.3%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
12,394
Price
$16.33
Total Value
$202.44K
Shares Held After
39,900
% of Holdings
23.7%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
16,509
Price
$11.67
Total Value
$192.66K
Shares Held After
137,044
% of Holdings
10.8%
CRESCENT BIOPHARMA, INC. (CBIO)
Bispham Barbara Harlin — General Counsel and Corporate Secretary.
Shares
620
Price
$17.90
Total Value
$11.10K
Shares Held After
18,710
% of Holdings
3.2%
CRESCENT BIOPHARMA, INC. (CBIO)
Scalzo Richard William — Chief Financial Officer
Shares
568
Price
$17.90
Total Value
$10.17K
Shares Held After
19,730
% of Holdings
2.8%
CRESCENT BIOPHARMA, INC. (CBIO)
Im Ellie Eunkyung — Chief Medical Officer
Shares
623
Price
$17.90
Total Value
$11.15K
Shares Held After
21,446
% of Holdings
2.8%
CRESCENT BIOPHARMA, INC. (CBIO)
Pinkas Jan — Chief Scientific Officer
Shares
658
Price
$17.90
Total Value
$11.78K
Shares Held After
21,581
% of Holdings
3.0%
CRESCENT BIOPHARMA, INC. (CBIO)
Brumm Joshua T — Director
Shares
1,610
Price
$17.90
Total Value
$28.82K
Shares Held After
279,602
% of Holdings
0.6%
CRESCENT BIOPHARMA, INC. (CBIO)
McNeill Jonathan — President and COO
Shares
731
Price
$17.90
Total Value
$13.08K
Shares Held After
138,427
% of Holdings
0.5%
CRESCENT BIOPHARMA, INC. (CBIO)
Lynch Ryan — Treasurer, Senior Vice President of Finance and Chief Accounting Officer.
Shares
240
Price
$17.90
Total Value
$4.30K
Shares Held After
13,631
% of Holdings
1.7%
ICON PLC (ICLR)
CLIMAX JOHN DR — Director
Shares
5,005
Price
$175.00
Total Value
$875.88K
Shares Held After
2,087
% of Holdings
70.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$505.20
Total Value
$60.62K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,182
Price
$504.17
Total Value
$595.93K
Shares Held After
324,563
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,538
Price
$503.53
Total Value
$774.43K
Shares Held After
325,745
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,160
Price
$502.44
Total Value
$1.09M
Shares Held After
327,283
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
708
Price
$501.52
Total Value
$355.08K
Shares Held After
329,443
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
492
Price
$500.19
Total Value
$246.10K
Shares Held After
330,151
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,220
Price
$499.15
Total Value
$608.97K
Shares Held After
330,643
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,080
Price
$498.45
Total Value
$1.04M
Shares Held After
331,863
% of Holdings
0.6%
908 Devices Inc. (MASS)
Kenneweg John — SVP, Sales&Product Marketing
Shares
21,399
Price
$10.11
Total Value
$216.34K
Shares Held After
57,784
% of Holdings
27.0%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
OLDAKOWSKI JOSEPH FRANK — VP OF FINANCE AND CONTROLLER
Shares
3,170
Price
$4.64
Total Value
$14.71K
Shares Held After
275,897
% of Holdings
1.1%
Guardant Health, Inc. (GH)
Azar Alex M II — Director
Shares
826
Price
$175.00
Total Value
$144.55K
Shares Held After
825
% of Holdings
50.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Posard Matthew L. — Director
Shares
4,000
Price
$108.99
Total Value
$435.96K
Shares Held After
58,839
% of Holdings
6.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Posard Matthew L. — Director
Shares
8,896
Price
$108.04
Total Value
$961.12K
Shares Held After
62,839
% of Holdings
12.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Posard Matthew L. — Director
Shares
3,000
Price
$106.83
Total Value
$320.48K
Shares Held After
71,735
% of Holdings
4.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Posard Matthew L. — Director
Shares
3,100
Price
$106.13
Total Value
$329.01K
Shares Held After
74,735
% of Holdings
4.0%
Guardant Health, Inc. (GH)
Krognes Steve E. — Director
Shares
971
Price
$177.48
Total Value
$172.33K
Shares Held After
7,906
% of Holdings
10.9%
Guardant Health, Inc. (GH)
Krognes Steve E. — Director
Shares
1,300
Price
$176.34
Total Value
$229.24K
Shares Held After
8,877
% of Holdings
12.8%
Guardant Health, Inc. (GH)
Krognes Steve E. — Director
Shares
3,300
Price
$175.42
Total Value
$578.89K
Shares Held After
10,177
% of Holdings
24.5%
Guardant Health, Inc. (GH)
Krognes Steve E. — Director
Shares
1,103
Price
$174.46
Total Value
$192.43K
Shares Held After
13,477
% of Holdings
7.6%
TENAX THERAPEUTICS, INC. (TENX)
Doogan Declan — Director
Shares
53,000
Price
$1.92
Total Value
$101.76K
Shares Held After
55,274
% of Holdings
95.9%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
96,125
Price
$63.64
Total Value
$6.12M
Shares Held After
432,886
% of Holdings
18.2%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
99,716
Price
$63.26
Total Value
$6.31M
Shares Held After
529,011
% of Holdings
15.9%
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
47,746
Price
$63.61
Total Value
$3.04M
Shares Held After
98,197
% of Holdings
32.7%
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
65,104
Price
$63.12
Total Value
$4.11M
Shares Held After
145,943
% of Holdings
30.8%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
79,113
Price
$63.65
Total Value
$5.04M
Shares Held After
117,066
% of Holdings
40.3%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
93,604
Price
$63.25
Total Value
$5.92M
Shares Held After
196,179
% of Holdings
32.3%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
200
Price
$356.87
Total Value
$71.37K
Shares Held After
221,314
% of Holdings
0.1%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
800
Price
$355.95
Total Value
$284.76K
Shares Held After
221,514
% of Holdings
0.4%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
450
Price
$354.91
Total Value
$159.71K
Shares Held After
222,314
% of Holdings
0.2%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
1,400
Price
$353.83
Total Value
$495.36K
Shares Held After
222,764
% of Holdings
0.6%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
100
Price
$349.05
Total Value
$34.90K
Shares Held After
224,164
% of Holdings
0.0%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
200
Price
$348.02
Total Value
$69.61K
Shares Held After
224,264
% of Holdings
0.1%
Inhibrx Biosciences, Inc. (INBX)
Kayyem Jon Faiz — Director
Shares
5,000
Price
$100.00
Total Value
$500.00K
Shares Held After
429,360
% of Holdings
1.2%
Amphastar Pharmaceuticals, Inc. (AMPH)
Zhou Rong — SENIOR EVP, PRODUCTION CENTER
Shares
10,000
Price
$23.94
Total Value
$239.40K
Shares Held After
169,203
% of Holdings
5.6%
Guardant Health, Inc. (GH)
Tariq Musa — Director
Shares
116
Price
$175.00
Total Value
$20.30K
Shares Held After
11,449
% of Holdings
1.0%
Beta Bionics, Inc. (BBNX)
Hopman Mark — Chief Commercial Officer
Shares
30,779
Price
$20.13
Total Value
$619.64K
Shares Held After
56,479
% of Holdings
35.3%
Beta Bionics, Inc. (BBNX)
Mensinger Mike — Chief Product Officer
Shares
2,650
Price
$22.00
Total Value
$58.30K
Shares Held After
177,390
% of Holdings
1.5%
Showing 651–700 of 1730 transactions (page 14 of 35)